drugset / Trial / NCT05540912

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

NCT05540912

Phase 1 Completed 30 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

Timeline

Start
2022-09-15
Primary completion
2022-11-15
Completion
2022-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-828 Unknown
Subject D064 Unknown
Subject D701 Unknown

Indications